Single intranasal immunization with attenuated Wuhan-like SARS-CoV-2 provides highly effective cross-protection against Delta and Omicron VOCs
Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Oct. 9, 2023
Abstract
Despite
the
end
of
COVID-19
pandemic,
problem
vaccine
prevention
this
disease
appears
highly
relevant.
The
emergence
and
widespread
distribution
Omicron
SARS-CoV-2
variant
concern
(VOC)
its
sublineages
has
dramatically
reduced
efficacy
vaccination
with
licensed
vaccines.
possible
approach
to
solving
is
develop
a
nasal
live
attenuated
(LAV)
capable
activating
humoral,
mucosal,
cell-mediated
immunity,
providing
prolonged
immune
response
cross-protection
against
different
VOCs.
aim
present
study
was
determine
immunization
cold-adapted
Wuhan-like
D-D2
strain
homologous
heterologous
challenges.
Single
intranasal
golden
Syrian
hamsters
showed
high
immunogenicity:
seroconversion
evident
in
all
immunized
animals.
absence
infectious
virus
lung,
passages,
brains
animals
allows
us
characterize
immunity
as
"sterile"
consistent
viral
RNA
concentration
organs
on
fourth-day
post-challenge.
Comparison
data
reproduction
organs,
weight
dynamics,
morphological
changes
lungs
unimmunized
that
provides
effective
protection
infection
development
pneumonia
when
challenged
both
ancestral
Delta
(B.1.617.2.122)
(sublineages
BA.1
BA.5.2)
variants.
Thus,
variants
have
great
potential
for
vaccines
their
basis.
Language: Английский
Single intranasal immunization with attenuated Wuhan-like SARS-CoV-2 provides highly effective cross-protection against Delta and Omicron variants of concern
Journal of microbiology epidemiology immunobiology,
Journal Year:
2024,
Volume and Issue:
101(1), P. 36 - 51
Published: March 9, 2024
Introduction.
Despite
the
end
of
COVID-19
pandemic,
problem
vaccine
prevention
this
disease
appears
highly
relevant.
The
emergence
and
widespread
distribution
Omicron
SARS-CoV-2
variant
concern
(VOC)
its
sublineages
has
dramatically
reduced
efficacy
vaccination.
possible
approach
to
solving
is
develop
a
nasal
live
attenuated
capable
activating
humoral,
mucosal,
cell-mediated
immunity,
providing
prolonged
immune
response
cross-protection
against
different
VOCs.
aim
study
was
determine
immunization
with
cold-adapted
Wuhan-like
D-D2
strain
homologous
heterologous
challenges.
Materials
methods.
conducted
on
an
animal
model
coronavirus
pneumonia
in
golden
Syrian
hamsters.
assessed
by
comparing
dynamics
weight,
viral
load
organs
histopathological
changes
lungs
immunized
unimmunized
animals.
Results.
Single
intranasal
hamsters
showed
high
immunogenicity:
seroconversion
evident
all
provides
effective
protection
development
productive
infection
when
challenged
both
ancestral
virus
strains
related
Delta
(AY.122)
(sublineages
BA.1.1
BA.5.2)
variants.
Conclusion.
attenuation
promising
strategy
for
vaccine.
Language: Английский